Conference Program

15th Annual Conference of the SSBMT/ EBMT 2026

15–16 May 2026 Holiday Inn Al Qasr, Riyadh
Download the PDF Directions Details
08:00 – 08:30
Registration
Break
08:30 – 08:35
Welcome Remarks – SSBMT
Ahmed Alaskar
Highlight
08:35 – 08:40
Welcome Remarks – EBMT
Ibrahim Yakoub-Agha
Highlight
08:40 – 08:45
Awarding of Certificates – Sponsoring Companies
Highlight
08:45
Session I
Moderators: Shahbaz Memon / Abdullah Aljefri
Session
08:45 – 09:10
Rejuvenating the cord blood transplantation
Mayada Abu Shanap
Session
09:10 – 09:35
Sequencing of bispecific and CAR-T
Mohamad Mohty
Session
09:35 – 10:00
Philadelphia-Negative Acute Lymphoblastic Leukemia in Pediatrics: Frontline and Salvage Strategies
Mohammed Eltaweel
Session
10:00 – 10:15
SSBMT General Assembly (restricted to SSBMT members)
Break
10:15 – 10:25
Coffee Break
Break
10:25 – 11:00
Navigating Treatment Options After cBTKi Failure: An Evidence-Based Discussion
Supported by Lilly · Speaker: Omar Albanyan · Moderator: Ahmed Alaskar
Symposium
11:00
Session II
Moderators: Bader Alahmari / Ayman Almozaini
Session
11:00 – 11:35
Supplementation and Supportive Strategies in GvHD – Practical Implications
Zinaida Peric
Session
11:35 – 12:10
Optimizing Treatment Strategies in Multiple Myeloma: A Focus on BCMA
Supported by GSK · Omar Zeid Abduljalil
Symposium
12:10 – 13:30
Juma'ah Prayer / Lunch Break
Break
13:30
Session III
Moderators: Mohammad Bakkar / Mohammed Althobaiti
Session
13:30 – 14:00
Navigating the Evolving Landscape of Relapsed/Refractory Chronic Lymphocytic Leukemia: 2026 Management Updates
Musa Alzahrani
Session
14:00 – 14:30
Armored and in vivo Next-Gen CARs
He Huang
Session
14:30 – 15:00
The use of expanded cord in patients with high risk malignancies
Guy Sauvageau
Session
15:00 – 15:30
Definition of clinical outcome for transplantation and gene therapy in Thalassemia and Sickle cell disease
Valeria Maria Pinto
Session
15:30 – 15:45
Coffee Break
Break
15:45
Session IV
Moderators: Ahmed Alfawazi / Aamer Aleem
Session
15:45 – 16:15
Advancing cGVHD Care – from Evidence to Practice
Supported by Sanofi · Bader Alahmari
Symposium
16:15 – 16:40
What are the current common approaches to treat CML?
Ayel Yahya
Session
16:40 – 17:05
AML: Focus on Menin Inhibitors
Bader Alahmari
Session
17:05 – 17:30
Advances in MPN
Rawan Almohamady
Session
17:30 – 18:00
From Evidence to Action: Real-World Management of Myelofibrosis Patients
Supported by GSK · Ayman Almozaini
Symposium
18:00 – 18:15
Panel Discussion
Session
18:15
End of Day 1
Highlight
08:30
Session I
Moderators: Husam Alsadi / Ayman Saad
Session
08:30 – 09:00
Guidelines and key determinants for treatment choice across SAA patient profiles
Antonio Risitano
Session
09:00 – 09:30
Integrating novel agents and allogeneic HCT in myelofibrosis
Juan Carlos Hernandez Boluda
Session
09:30 – 09:55
Paroxysmal Nocturnal Hemoglobinuria
Ashraf Warsi
Session
09:55 – 10:25
Advancing Myelofibrosis Care: From Disease Burden to Real-World Case Insights
Supported by Sobi · Omar Albanyan / Ayel Yahya
Symposium
10:25 – 10:35
Panel Discussion
Session
10:35 – 10:45
Coffee Break
Break
10:45
Session II
Moderators: Amal Al Abdulwahab / Abdullah Aljefri
Session
10:45 – 11:15
Gene Editing Therapy Updates for SCD and TDT Patients
Supported by Vertex · Fahad Al-Manjomi
Symposium
11:15 – 11:45
HLH and IEC-HS
Hind Salama
Session
11:45 – 12:15
TA-TMA diagnostic criteria
Eleni Gavriilaki
Session
12:15 – 12:45
Hemoglobinopathies
Selim Corbacioglu
Session
12:45
Lunch Break – End of Day 2 (Main Conference)
Break
13:15
13th Annual Saudi Hem/Onc Nurses Meeting
Highlight
13:15 – 13:30
Registration (Nurses Meeting)
Break
13:30 – 13:40
Welcome Remarks – SSBMT Nurses Group
Maryam Almutairi
Highlight
13:40 – 13:50
Welcome Remarks – EBMT Nurses Group
Hilda Mekelenkamp
Highlight
13:50
Nurses Session I
Moderators: Maryam Almutairi / Suha Alkhraisat
Session
13:50 – 14:10
Best of the best of EBMT 2026
Hilda Mekelenkamp
Session
14:10 – 14:30
Malignant hematology & recent update in HL
Izaskun Zeberio
Session
14:30 – 14:50
The impact of novel therapies on clinical nursing education
Silvia Gnecchi
Session
14:50 – 15:10
Leukemia & Multiple Myeloma Overview
Suha Alkhraisat
Session
15:10 – 15:20
Panel Discussion
Session
15:20 – 15:30
Coffee Break
Break
15:30
Nurses Session II
Moderators: Maryam Almutairi / Suha Alkhraisat
Session
15:30 – 15:50
Enhance the transplant rate in SCD patients
Maram Haddad
Session
15:50 – 16:10
Outpatient transplant for Lymphoma Patient
Hamzah Alquran
Session
16:10 – 16:30
CAR-T Patient Journey from screening to infusion
Belal Albtoosh
Session
16:30 – 16:50
Setting Up a Bone Marrow Transplant (BMT) Center
Mohammed Bashir
Session
16:50 – 17:10
Empowering nurses to care for patients receiving cellular and bispecific therapies
Belal Alblowe
Session
17:10 – 17:20
Panel Discussion
Session
17:20
Closing Remarks
Highlight